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STRUCTURED ABSTRACT 
Background: Colorectal cancer (CRC) is the third most common cancer worldwide, especially in 
developed countries where an estimated 60% of all cases occur. There is evidence of a higher risk in 
Western society whose behaviours are characterised by higher consumption of red and processed 
meat than in people living along Mediterranean coast, who have a decreased overall cancer 
mortality correlated to eating habits such as Mediterranean Diet. 
Aim: This review evaluate the correlation between 3 components of MedD (olive oil, red wine and 
tomatoes) and incidence and progression of CRC. 
Methods: a literature scanning was conducted using key words “Colorectal cancer” “dietary pattern” 
“Mediterranean Diet” “olive oil” “protective effects” “resveratrol” “lycopene”. Olive oil 
polyphenols, red wine resveratrol and tomatoes lycopene showed several capabilities in vitro to 
interfere with molecular cancer pathways, at the same time many clinical studies reported their 
ability to reduce cancer initiation and progression. More clinical studies are needed to identify the 
precise dose and way of administration of single agents or their combination to produce a 
coadjutant treatment to the ones already applied in chemoprevention and oncological treatment.  
 
Key words: Mediterranean Diet; Colorectal cancer; polyphenols; resveratrol; lycopene. 
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ABBREVIATIONS: 
CRC = Colorectal Cancer 
MedD = Mediterranean Diet 
HT= hydroxytyrosol 
EVOO= extra-virgin olive oil 
ROS= reactive oxygen species 
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INTRODUCTION 
In the world colorectal cancer (CRC) is the third most frequent cancer, especially in developed 
countries where an estimated 60% of all CRC cases occur. [1,2] There is evidence of a higher CRC 
risk in Westernized society whose behaviours are characterised by higher consumption of red and 
processed meat than in people living along Mediterranean coast, who have a decreased overall 
cancer mortality correlated to their eating habits such as Mediterranean Diet. [3] 
In 2010 UNESCO recognized the Mediterranean Diet (MedD) as an “intangible cultural heritage of 
Italy, Greece, Spain and Morocco” for multiple reasons such as the preservation of local 
biodiversity and a variety of health benefits starting from a reduction of colorectal cancer risk and 
the percentage of deaths caused by cardiovascular accidents. [4,5,6] 
Mediterranean diet is characterized by an high consumption of fruits, vegetables and complex 
carbohydrates, followed by a low amount of fish and meat and a daily glass of red wine; in this diet 
the mainly source of fat is olive oil. [7] 
CRC prevention has an important public health implication. Many studies have demonstrated that 
fibres and phytochemicals included in MD have a strong chemo preventive role in the onset of 
CRC. [8,9] 
The Italian Cancer Register published in 2015 data of prevalence and incidence of CRC in Italy, in 
particular: prevalence of CRC in 2015 in North-West Italy was 764 and in North-East part was 775 
instead, a difference could be found analysing data from The Southern part of Italy with their 437 
cases of CRC in 2015. Maybe these great differences could be explained by different lifestyle and 
primarily different eating habits, where in the South there is a clearly Mediterranean diet. [10] 
Common mutations, chromosomal changes and translocations have been reported to affect 
important pathways (WNT, MAPK/PI3K, TGF-β, TP53), and mutations in colon cancer cells. [11] 
(figure 1). We focused on clinical studies evaluating some specific components of the 
Mediterranean Diet. 
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The association between MedD and CRC have already been examined by many clinical studies, 
case-control and cohort types through questionnaires analysing dietary intakes of nutrients; the 
resulted scores and indexes showed and inverse association between the use of MedD and the risk 
of CRC. [12,13,14,15] Although these results in vivo, the difficult interpretation relies in the real 
role played by single compound of Mediterranean Diet in prevention of CRC, moreover some 
measurement bias in dietary questionnaire and their scores may exist. Therefore others studies 
analysed if there is any association between MedD and a changing in blood concentrations of 
vitamins A, C and E included in most part of MD foods, these have generally been inconclusive or 
reporting only a possible preventive action for vitamin A, vitamin E and β-carotene. [16,17,18] 
Thus pre-clinical studies play a key role in understanding how single MedD compound modifies 
molecular pathways of signalling in human colon cell lines to prevent CRC onset. In fact pre-
clinical studies have always been focused on the effects that each component of the MedD could 
exerts on this kind of cancer cells to better understand their pathways and molecular mechanism of 
action affected by each dietary compounds [19]. In this regard, this review is focused on: olive oil, 
red grapes and tomatoes. 
This review aimed to evaluate the correlation between 3 main protagonists of MedD (olive oil, red 
wine and tomatoes) and the incidence of CRC in clinical studies to support the ideal 
“chemoprevention” strategy by the routinely consumption of macro and micronutrients included in 
MedD. 
WHAT DOES THIS PAPER ADD TO LITERATURE 
Clinical and pre-clinical studies have always been always adding more data to support the 
hypothesis that the MedD could protect from colorectal cancer. In this background, our paper would 
aim to add to literature an organised review of clinical and pre-clinical studies about the 
chemopreventive role of 3 major components of MedD: olive oil with its polyphenols, red wine 
with its resveratrol, and tomatoes with their lycopenes. 
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OLIVE OIL POLYPHENOLS 
Olive oil is a central compound in MD and is the main source of dietary fat. MD style is 
distinguishable from other healthy dietary models for its high-fat content. [5,12] Many experimental 
evidences outline the biological and molecular mechanism by which each component of olive oil 
could realize multiple health benefits. [20,21,22] The consumption of olive oil exerts a protective 
effect in reducing firstly CRC risk and many other types of cancer risk, including prostatic cancer, 
the breast ones. [23,24] This property has been referred to its content of monounsatured fats, 
principally oleic acid. [19] However olive oil is a functional and complex food and it contains 
several minor bioactive compounds including tocopherols, squalene, alcohols and many 
polyphenols such as oleuropein, hydroxytyrosol and tyrosol which represent approximately the 80% 
of olive oil’s phenolic content. [21,25] 
Although the mechanisms involved remain uncertain, thanks to preclinical studies it has been 
attributed to olive oil’s components many chemopreventive effects mostly because they interfere 
with the initiation, promotion and progression of cancerogenesis pathways. [21,25, 26] (Tab 1). 
Dietary fat has been implicated to cancer development, either positively or negatively. 
Many case control studies were conducted to find out an epidemiological correlation between 
digestive system cancers (stomach, colorectum and pancreas) and olive oil. Psaltopoulou et al made 
a meta-analysis studying eight case-control studies and found that a high intake of olive oil could 
lead to a significant 30% lower probability of having digestive system cancers than a lower intake 
of olive oil. [31] Moreover, in Italy a large case-control study including 1953 patients with 
colorectal carcinoma (1225 colon and 728 rectum) and 4154 controls, the ORs for successive 
tertiles, compared with the lowest one, were 0.87 (95%CI 0.75 to 1.01) and 0.83 (95%CI 0.70 to 
0.99) (p = 0.03) in colorectal carcinoma.  Analyzing colon and rectal carcinoma separately Authors 
found a ORs of 0.82 (95%CI 0.68 to 0.98) and 0.81 (95%CI, 0.66 to 0.99) (p=0.04), and 0.96 
(95%CI 0.77 to 1.19) and 0.88 (95% CI 0.66 to 1.12) respectively. In the same population 
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monounsaturated fat intakes appeared uninfluential [32]. Similar results were obtained by Benito et 
al. [33]. The OR for an increment of one portion of fried foods per week was 0.89 for colon cancer, 
0.97 for rectum and 0.93 for colorectum, for the use of olive oil [34]. Meta-analysis of prospective 
cohort studies suggest that cancer morbidity and mortality are lower in Mediterranean countries, 
where olive oil represents an important quote of dietary fat [35]. 
Trichopoulou and Co-Authors by using a straightforward formula suggested by Wahrendorf [36] 
hypotesize that people of industrial countries could reduce their incidence of colorectal cancer by 
∼25% by switching from a Western diet (weighted relative risk calculated by summing the products 
of the fraction of the population in each quintile of Mediterranean diet score with the relative risk of 
colorectal cancer for the quintile = 0.2*1 + 0.2*2.5 + 0.2*4.0 + 0.2*5.5 + 0.2*7 = 4.00) to a 
Mediterranean diet (weighted relative risk = 0.37*1 + 0.2*2.5 + 0.2*4.0 + 0.2*5.5 + 0.03*7 = 2.98)  
[37]. 
Stoneham and his coworkers conducted an ecological study using international databases from 28 
countries. Their aim was to calculate the relation between CRC and dietary factors. Using a 
multiple regression they concluded that 76% of the intercountry variation in CRC incidence rates 
could be caused by three main dietary foods: meat, fish and olive oil. A positive association resulted 
for meat and fish instead of an inverse correlation found between olive oil and CRC risk.  Olive oil 
may exert its protective effect influencing polyamine metabolism in cells leading to a reduction in 
cancerogenesis progression. [38] 
Recently, Steck and Co-Workers associated colon rectal cancer risk, Med D Score and the Healthy 
Eating Index (HEI) furthermore; and define a novel Dietary Inflammatory Index (DII). Comparing 
different published studies (US and European patients), the authors concluded that higher MedD 
score were associated with lower colorectal cancer risk (8-54%), as well as higher HEI scores were 
associated with lower colorectal cancer risk (20-56%). [39].  
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RED GRAPES AND RESVERATROL 
Resveratrol is a phenolic compound mainly represented in the external skin of red grapes but also in 
other vegetables (for example berries and nuts). In MedD, resveratrol can be found mainly in red 
wine. However its concentration in red wine varies widely depending upon which quality of red 
grapes species and the climate. [40] 
Resveratrol has pleiotropic pharmacological properties such as the repression of platelet 
aggregation, and eicosanoid synthesis. It promote the protection from ROS damage and from 
flogistic events resulting in cardiovascular protective benefits and, certainly, anti-cancer activities. 
[41,42]  
Although it is difficult to ascertain the cause and effect mechanism in in vivo settings, resveratrol 
has been shown to affect a number of molecular targets, based on cancer type, resveratrol 
formulations, stage of disease, and dose and duration of resveratrol. It is being increasingly 
appreciated that the combinatorial approaches of resveratrol with other natural agents are likely to 
be especially useful in advanced stages of cancers because of deregulation of multiple pathways 
affecting cancer cell growth and oncogenic signalling. [43,44] 
Several preclinical and clinical studies have reported the beneficial effects of resveratrol in tumour 
prevention. [45,46,47,48] One of the major interesting topics investigated was the precise amount of 
red wine that has these beneficial effects. Resveratrol has been found to be safe and well-tolerated 
at up to 5 g/day, either as a single dose or as part of a multiple-day dosing comsumption [49]. 
However, when using resveratrol in cancer patients, it is important to remaind that these studies 
were done in healthy populations. 
Patel et al. studied how twenty CRC patients reacted to a daily oral administration of resveratrol 
such as 0.5 g or 1.0 g for 8 days prior to surgery. Detecting resveratrol-metabolites in CRC 
resection tissue, they found that resveratrol decreased volume tumour by 5%. [48] These data 
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support the hypothesis that resveratrol, as a MedD component, plays a role as a chemopreventive 
agent even if  these doses are not attainable by normal consumption of wine. 
Kontou, Psaltopoulou and their colleagues studied 250 Greek CRC patients using questionnaires 
assessing their clinical and lifestyle characteristic and their adherence to Mediterranean diet 
evaluated through MedDietScore. They demonstrated that an intake less than 12g of alcohol per day 
significantly reduces coloncancer risk in men and women. However there was a significant 
reduction resveratrol-related of CRC risk odds more in men than in women. According to 
Psaltopoulou and Kontou Mediterranean-style diet is independently related to a decrease of CRC 
risk both in men and women. [47]  
Crockett et al performed a retrospective study analysing 1033 cases and 1011 controls from North 
Carolina and they found that moderate alcohol intake (especially from wine) was negatively 
associated with distal colon and rectal cancer. [50]  
Previous meta-analyses of studies on alcohol intake and risk of colorectal cancer (CRC) have shown 
that alcohol increases risk in a linear dose-related manner. [51,52,53] 
The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) reported 
that alcohol consumption increased the risk of CRC with a summary relative risk of 1.06 (95% CI, 
1.01 to 1.12) per 10 g of alcohol consumed per day [54]. 
Several studies have reported that the association between alcohol intake and CRC is stronger in 
men than in women. [52,55] On contrary the Norfolk UK cohort showed that daily consumption of 
1 or more units of wine was inversely related to CRC risk (HR 0.61; 95% CI, 0.44 to 0.94), with no 
evidence for sex- specific relationships [56]. Moreover the North Carolina Colon Cancer study 
found that moderate intake of wine was inversely associated with CRC (OR 0.69; 95% CI, 0.56 to 
0.86). [50] 
However, a meta-analysis showed that even moderate alcohol intake was related to increased risk 
for CRC (relative risk, 1.21; 95% CI, 1.13 to 1.28) [57]  
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Preclinical studies suggested a potential beneficial effects of resveratrol however clinical studies 
lead to controversial results. The reason is possibly related to dose and types of alcoholic beverages. 
 
TOMATOES AND LYCOPENE 
According to Smith “tomato pills cure all your ills” [58]: in fact tomatoes, central protagonists in 
MD, have several beneficial effects especially in the prevention of cardiovascular diseases, 
osteoporosis and cancer. A reduction of CRC risk more than 20% has been linked to the daily intake 
of vegetables, including tomatoes. [59] This extraordinary action of tomatoes has been attributed to 
their elevated content of carotenoids, first of all b-carotene and lycopene. [60,61] 
 Lycopene is synthesized by plants and confers red colours not only to tomatoes but also to red 
oranges and apricots. After the consumption of tomatoes, lycopene plasma concentration is 
dependent upon several biological mechanisms; in fact lycopene is modified during the digestive 
process decreasing its bioavailability. To facilitate lycopene absorption is better to introduce 
tomatoes in combination with lipids like it happens in sauces or juices. [62] 
In a randomised cross-over trial a daily low-carotenoid diet based on daily 330 ml tomato or carrot 
juice was compared. At the end of the study faecal water showed an elevate dose-related 
cytotoxicity and the ability to suppress cancer cell proliferation on colon adenocarcinoma cells 
HT29. These results suggested that 2 week interventions with carotenoid-rich and lycopene-rich 
juices could led to changes in luminal biomarkers relevant to colon carcinogenesis. [63] 
Walfisch et al suggested that high level serum of insulin-like growth factor in colon cancer patients 
is a marker of augmented risk of colon cancer. They showed that plasma concentration of IGF 
factor-I reduced significantly by 25% using tomato lycopene extract supplementation. [64]  
The majority of case–control studies examined the association with CRC for carotenoids and 
vitamins using dietary intakes estimated from questionnaires. Most of these studies reported an 
inverse association between dietary vitamin C and CRC risk. [65] However, pooled analyses of 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
prospective studies showed no association between dietary intakes of carotenoids or between any of 
the vitamins A, C or E and CRC risk. [66,67] 
The European Prospective Investigation into Cancer and Nutrition (EPIC) case–control study 
assessed the association of prediagnostic plasma concentrations and dietary intakes of carotenoids 
and vitamins A, C and E with the risk of colon and rectal cancer. [68] 
They found that plasma retinol was inversely associated with (proximal) colon cancer and dietary 
intakes of dietary b-carotene and dietary vitamins E and C were inversely associated with (distal) 
colon cancer. Authors suggested a protective effect from fruit and vegetable consumption on 
carcinogenesis based on components with antioxidative properties [69]. However, clear evidence 
for this is still lacking.  
Previously observed associations for fruit and vegetable consumption and related fiber were found 
to be stronger for colon than for rectal cancer. [70,71] 
A recent  meta-analysis of studies evaluated  the association between lycopene consumption and the 
risk of colorectal cancer. The relative risk for highest versus lowest category indicated no 
significant association between lycopene consumption and the risk of colorectal cancer [RR = 0.94, 
95%  95%CI 0.80-1.10]. However, a significant inverse association was observed between lycopene 
consumption and the site of cancer in the colon (RR = 0.88, 95% CI: 0.81-0.96). [72] 
Further research will be needed in this area to provide conclusive evidence 
 
CONCLUSIONS 
MedD Lifestyle included a particular type of food and drink, which exerts a nutritional synergy 
when assumed in combination [6].  The traditional MedD is centred on the mainly assumption of 
fruits, vegetables and fish and low red meat intake. Several pre-clinical and clinical studies have 
focused on how a MedD dietary pattern could affect cancer initiation and progression. Olive oil 
polyphenols, red wine resveratrol and tomatoes lycopene are secondary anti-oxidants produced by 
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plants and they showed several capabilities in vitro to interfere with molecular cancer pathways, at 
the same time many clinical studies reported olive oil, red wine and tomatoes ability to reduce 
cancer initiation and progression.  
However due to the complex interaction between food and due to the bioavailability of antioxidants 
in man it is very difficult to define dose and dose-related effects. Moreover cancer results from the 
combine effects of many different factors such as: smoking habits, physical activity, genetic.  
More clinical studies are needed to identify the precise dose and way of administration to produce a 
coadjutant treatment to the ones already applied nowadays in oncology. Therefore the 
supplementation of vegetables and fruit with bright colours or nuts and almonds as in MedD is 
particularly recommended in cancer patients [6,73].  
A very recent evaluation of burden of cancer in European Counties found that former cigarette 
smoking combined was the risk factor responsible for the greatest cancer burden, but also adiposity 
play an important role. Ever smoking could explain 24.0% (95% CI = 22.2% to 26.0%) of total 
cancer burden followed by physical inactivity (4.9%, 95% CI = 0.8% to 8.1%) and adiposity (1.8%, 
95% CI = 0.2% to 2.8%). [74] 
In this review we focused on different components of MedD that could be useful in preventing 
CRC. More population studies are needed to confirm this data, however due to the good prevention 
of MedD in other different disease clinician can safely suggest this lifestyle approach to patients.  
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Tab 1 
 
Cellular effects of olive oil on colon cancer initiation and progression 
 Downregulation of COX – 2 (26) 
 Downregulation of BCL – 2 (27) 
 ROS generation in cancer cell (28) 
 Downregulation of EGFR expression (29) 
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Highlights 
• Colorectal cancer (CRC) is the third most common cancer worldwide and it has been  
correlated to eating habits such as Mediterranean Diet 
• Mediterranean diet is characterized by an high consumption of fruits, vegetables and 
complex carbohydrates, followed by a low amount of fish and meat and a daily glass of red 
wine; in this diet the mainly source of fat is olive oil 
• We focused on 3 components of MedD: olive oil, red wine and tomatoes. 
• Preclinical studies suggest that these components have chemopreventive effects. 
• More population studies are needed to confirm the efficacy of single component of MedD, 
however clinician can safely suggest this lifestyle approach to patients. 
 
